News

Brian Donnelly's Appointment as Chief Commercial Officer at Myriad

Brian Donnelly's Appointment as Chief Commercial Officer at Myriad

Myriad Genetics Welcomes Brian Donnelly as CCO

In an exciting development for the healthcare industry, Myriad Genetics, Inc. (NASDAQ: MYGN), renowned for its expertise in molecular diagnostics and precision medicine, has appointed Brian Donnelly as its Chief Commercial Officer (CCO). This pivotal role, effective from May 1, 2025, is expected to significantly influence the company’s trajectory in addressing health through genetic insights.

A Leader with a Proven Track Record

Brian Donnelly is bringing over 20 years of extensive experience in healthcare, diagnostics, and medical technology to Myriad Genetics. His impressive career showcases a wealth of expertise in leading high-performing teams and managing large-scale operations. Donnelly has a reputation for crafting innovative go-to-market strategies that drive substantial growth and facilitate operational excellence.

Sam Raha, the newfound president and CEO of Myriad Genetics, expressed confidence in Donnelly’s abilities, stating, “Brian combines strategic foresight with operational skills and a heartfelt commitment to patient-centric solutions, which make him an invaluable addition to our leadership team.” This sentiment underscores the high expectations placed on Donnelly as he steps into his new role.

Commitment to Healthcare Innovations

Donnelly, eager to embark on this journey with Myriad, articulated his passion for the company’s mission. He emphasized the importance of providing essential genetic information to empower patients, healthcare professionals, and partners alike. His vision includes enhancing the company’s impact while fostering a culture of innovation and growth, ensuring that every decision aligns with advancing health and well-being for all.

Experience with Industry Giants

Before joining Myriad Genetics, Donnelly made notable contributions in senior commercial and management roles at prestigious organizations like Ancestry, Amazon, and Illumina. His previous experiences have equipped him with insights into aligning commercial strategies with broader organizational objectives and have helped enhance brand positioning significantly.

This wealth of knowledge and experience poise him well to support Myriad's objectives to develop innovative molecular tests aimed at assessing disease risks and guiding treatment decisions across diverse medical specialties. His work is expected to lower healthcare costs while simultaneously improving patient outcomes.

About Myriad Genetics

Myriad Genetics stands out as a leader in the realm of molecular diagnostics testing and precision medicine, committed to enhancing health and wellness for the global community. The company is dedicated to creating molecular tests that both assess the risk of diseases and direct treatment options where molecular insights markedly improve patient care.

These advancements contribute not only to better health outcomes but also align with efforts to reduce the associated healthcare expenditures significantly. The overarching goal is clear: empowering healthcare professionals and patients with actionable genetic insights to make informed decisions.

Communication and Outreach Efforts

Myriad Genetics remains dedicated to open communication with its stakeholders. For investor inquiries, the company provides direct contact to Matt Scalo at (801) 584-3532 or via email at IR@myriad.com. Moreover, media inquiries can be directed to Kate Schraml at (224) 875-4493, with the option to reach her at PR@myriad.com. These contact points reflect Myriad's commitment to transparency and engagement.

Frequently Asked Questions

What is the role of Brian Donnelly at Myriad Genetics?

Brian Donnelly has been appointed as the Chief Commercial Officer, responsible for leading the commercial strategy to drive growth and innovation.

What experience does Donnelly bring to Myriad Genetics?

Donnelly brings over 20 years of experience in healthcare and diagnostics, having held senior roles at companies like Ancestry, Amazon, and Illumina.

How does Myriad Genetics impact patient care?

Myriad Genetics develops molecular tests that help assess disease risks and guide treatment decisions, thereby improving patient care significantly.

What is the mission of Myriad Genetics?

Myriad’s mission focuses on advancing health and well-being for all through innovative molecular diagnostics and precision medicine.

How can stakeholders contact Myriad Genetics?

Investors can contact Matt Scalo at (801) 584-3532, while media can reach out to Kate Schraml at (224) 875-4493 for inquiries.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

G-STAR & Wu-Tang Clan Unleash Denim Fusion

Updated Category News Views 5

Denim and Old-School Beats: A Fresh Partnership Just when you think fashion collaborations have run their course, along comes something worth the buzz. This fall, G-STAR, the edgy Dutch denim frontrunner, and the legendary hip-hop collective of Wu-Tang Clan are shaking up the apparel scene, blending raw denim with raw rap. It's a multi-year collaboration that doesn't slap...

Continue Reading
NOAA Taps ICEYE US for Game-Changing SAR Satellite Data

Updated Category News Views 6

The Strategic Move to SAR Data Imagine this: You’re in the thick of a hurricane, where visibility goes out the window, and traditional satellite data chokes under the crushing weight of clouds and nightfall. That's the precise chaos ICEYE US is cutting through with its Synthetic Aperture Radar (SAR) technology. The latest scuttlebutt is that NOAA's getting cozy with...

Continue Reading
CSS Revamps Identity, Emphasizing Senior Living Tech

Updated Category News Views 5

CSS Takes a Bold Step with a Fresh Brand Identity Every now and then, you see a company shake off the old coat and put on a polished new one. That's what CSS is doing with its updated brand, staking its claim as a heavyweight tech player in the senior living sector. No small feat, given the challenges stacked against these aging communities—tasked with keeping...

Continue Reading
Perk's U.S. Expansion: A Bold Move in Spend Control

Updated Category News Views 5

Perk Aims for U.S. Growth: Will It Pay Off? Amidst the cacophony of market chatter, Perk's announcement to bring its spend platform stateside is echoing louder than usual. This move is not just another step in its expansion but rather a leap considering the competition and market needs. In Europe, where they've already captured a chunk of the market with their Travel and...

Continue Reading
Mutare Sharpens Security for Webex Calls with Precision

Updated Category News Views 5

Control Dialed In: Tailored Call Screening Kicking things up a notch, Mutare is redefining call security by fine-tuning their Voice Security for Webex Calling. Imagine this—custom rules now let organizations shape a security policy down to the very last detail, ensuring unwanted calls don’t slip through the cracks. Wave goodbye to the broad-strokes approach. Precision...

Continue Reading
Cabot Wilds: Nova Scotia's Next Luxury Golf Haven

Updated Category News Views 7

Breaking New Ground in Golf and Luxury Cabot and the Bragg family are cooking up something extraordinary in Cumberland County, Nova Scotia. The new luxury lifestyle and golf destination, Cabot Wilds, promises to be more than just a retreat—it's a bold statement on how to marry nature, luxury, and community. Set to open in late 2027, this expansive 2,500-acre resort will...

Continue Reading
Alcott HR's Sales Strategy Gets a Boost with New Hire

Updated Category News Views 9

Alcott HR Ramps Up Sales Firepower Now here's something fresh from the world of human resources outsourcing—Alcott HR has grabbed a new ace for their sales team. Eldin Radoncic is the name you'll want to remember, folks, because he's diving headfirst into the Director of Sales seat at this IRS Certified and ESAC Accredited player based out in good old Farmingdale, New...

Continue Reading
Inovonics Duress Card Enhances Safety for K-12 and Beyond

Updated Category News Views 7

A New Dawn for Safety in Schools and More It's about time we talk about something more substantial than just beefing up security cameras or tightening door locks. Real-world problems require nimble solutions, and that's where Status Solutions steps in with the Inovonics Duress Card. It's not just another gadget; it's a lightweight, wrist-mounted lifeline designed to say,...

Continue Reading
Paula's Choice Elevates Skincare Game with New Campaign

Updated Category News Views 5

Strategy Meets Skincare: Paula's Choice in the Spotlight Catch this: Paula's Choice just dropped a moisturizer, but it ain't just lotion. No, the Pro-Collagen Peptide Plumping Intensive Moisturizer is here with a punch. And they've got Hannah Waddingham, of 'Ted Lasso' fame, fronting a campaign that screams confidence. Now, that's a way to announce your move at the...

Continue Reading
Lumicell Expands LumiSystem in Breast Cancer Surgery

Updated Category News Views 6

Innovation in Breast Cancer Surgery: A Real-World Game Changer? You’ve got your flashlight guiding a scared child through the dark, and in the healthcare world, Lumicell is promising to do just that for surgeons navigating the tricky maze of breast cancer surgery. Their LumiSystem is making waves in breast-conserving surgery—new kid on the block with a real chance at...

Continue Reading

Top 5 Most Recently Viewed Articles

Financial Trust Achieves New Heights in Investment Performance

Updated Category News Views 132

Financial Trust Asset Management Honored for Excellence Financial Trust Asset Management has received notable recognition by being included in the PSN Top Guns List for Q4 2024. This prestigious list, created by Zephyr, reflects the best-performing investment strategies in Managed Accounts, Separate Accounts, and ETFs. This recognition underscores the importance of...

Continue Reading
Amazing Winter Fest OC Experiences Await This Holiday Season

Updated Category News Views 404

Explore the Magic of Winter Fest OC Experience the joy of the holiday season at Winter Fest OC, the largest winter festival in Southern California. This popular festival is gearing up for its 2025 season, making it a must-visit event for families and friends looking to create unforgettable memories. With a fantastic lineup of attractions and flexible ticketing options,...

Continue Reading
US Dollar Faces Headwinds Amid Economic and Trade Challenges

Updated Category News Views 123

US Dollar Faces Challenges in a Dynamic Market The week has proven to be challenging for the US dollar, as shifting economic conditions and uncertainties surrounding trade have come into play. Expectations surrounding the Federal Reserve's policy and revived concerns about tariffs have caused the dollar to give up some of the strength it gained recently. This has been...

Continue Reading
ACS Revamps Colorectal Screening Guidelines for 2026

Updated Category News Views 4

Shaking Up the Colorectal Screening Scene When the American Cancer Society (ACS) turns heads with new guidelines, smart investors in the healthcare sector would do well to watch closely—not because there's a stock play here, but because it signals where public health might influence future healthcare systems and insurance policies. A New Chapter in Screening Options The...

Continue Reading
CAPREIT Completes Significant Property Sale for Affordable Housing

Updated Category News Views 174

CAPREIT's Strategic Sale Boosts Affordable Housing Initiatives Canadian Apartment Properties Real Estate Investment Trust (“CAPREIT”) (TSX:CAR.UN) has recently announced a pivotal move that underscores its commitment to social responsibility and community development. This transaction involves the disposition of an off-strategy portfolio, comprising 717 residential...

Continue Reading